ARTICLE
|
doi:10.20944/preprints201811.0609.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immune checkpoint inhibitors; immune-related adverse events (irAEs); tolerance; ipilimumab; nivolumab; interleukin-2; hyperthermia; low-dose-combination therapy
Online: 28 November 2018 (10:23:31 CET)
ARTICLE
|
doi:10.20944/preprints202008.0222.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Erlotinib; POLA2; DARTS LC-MS/MS; Resistance; NSCLC
Online: 9 August 2020 (21:26:35 CEST)
ARTICLE
|
doi:10.20944/preprints201910.0373.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
malignant melanoma; BRAF V600E mutation; proteomics; mass spectrometry genetics; heterogeneity; prognosis
Online: 31 October 2019 (10:36:32 CET)